About Avadel Pharmaceuticals
Avadel Pharmaceuticals is a company based in Dublin (Ireland) founded in 1990 was acquired by Alkermes in October 2025.. The company has 188 employees as of December 31, 2024. Avadel Pharmaceuticals has completed 1 acquisition, including Eclat Pharmaceuticals. Avadel Pharmaceuticals operates in a competitive market with competitors including Sirnaomics, Apnimed, Ensysce, Oxular and Arecor, among others.
- Headquarter Dublin, Ireland
- Employees 188 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avadel Pharmaceuticals Plc
-
Annual Revenue
$169.12 M504.79as on Dec 31, 2024
-
Net Profit
$-48.83 M69.53as on Dec 31, 2024
-
EBITDA
$-39.72 M70.81as on Dec 31, 2024
-
Latest Funding Round
$117.4 M (USD), Post-IPO
Mar 09, 2022
-
Investors
Alkermes
& 5 more
-
Employee Count
188
as on Dec 31, 2024
- Investments & Acquisitions
-
Acquired by
Alkermes
(Oct 22, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Avadel Pharmaceuticals
Avadel Pharmaceuticals is a publicly listed company on the NASDAQ with ticker symbol AVDL in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Avadel Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $117.4M
-
First Round
First Round
(02 Mar 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Post-IPO - Avadel Pharmaceuticals | Valuation |
investors |
|
| Feb, 2020 | Amount | Post-IPO - Avadel Pharmaceuticals | Valuation |
investors |
|
| Mar, 2018 | Amount | Debt – Conventional - Avadel Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avadel Pharmaceuticals
Avadel Pharmaceuticals has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Alkermes, RTW Investments and Vivo Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on biotechnology startups
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avadel Pharmaceuticals
Avadel Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Eclat Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gasket sheets and sealing solutions are manufactured for industrial applications.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Avadel Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avadel Pharmaceuticals Comparisons
Competitors of Avadel Pharmaceuticals
Avadel Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Apnimed, Ensysce, Oxular and Arecor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for obstructive sleep apnea are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| domain | founded_year | HQ Location |
Drug delivery platforms and therapeutics for ophthalmology are developed.
|
|
| domain | founded_year | HQ Location |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| domain | founded_year | HQ Location |
RNAi technologies are developed for treating rare orphan diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avadel Pharmaceuticals
Frequently Asked Questions about Avadel Pharmaceuticals
When was Avadel Pharmaceuticals founded?
Avadel Pharmaceuticals was founded in 1990 and raised its 1st funding round 28 years after it was founded.
Where is Avadel Pharmaceuticals located?
Avadel Pharmaceuticals is headquartered in Dublin, Ireland.
Who is the current CEO of Avadel Pharmaceuticals?
Gregory J Divis is the current CEO of Avadel Pharmaceuticals.
How many employees does Avadel Pharmaceuticals have?
As of Dec 31, 2024, the latest employee count at Avadel Pharmaceuticals is 188.
What is the annual revenue of Avadel Pharmaceuticals?
Annual revenue of Avadel Pharmaceuticals is $169.12M as on Dec 31, 2024.
What does Avadel Pharmaceuticals do?
Pharma company with proprietary drug delivery tools and drugs for narcolepsy. The company is involved in the development of its lead candidate FT218, which is a once nightly formulation of sodium oxybate designed to treat narcolepsy sleeping disorder. The company is also involved in commercialized some hospital (mainly injectables) and pediatric (oral formulations) care products. The company offers 4 main drug delivery technologies - micropump (precisely delayed drug release microcapsules), liquitime (oral liquid formulation with delayed-release formulation), triggerlock (a mechanism to prevent abuse in opiate analgesics), and medusa (hydrogel depot formulation for subcutaneous injections).
Who are the top competitors of Avadel Pharmaceuticals?
Avadel Pharmaceuticals's top competitors include Sirnaomics, Arcturus Therapeutics and Apnimed.
Is Avadel Pharmaceuticals publicly traded?
Yes, Avadel Pharmaceuticals is publicly traded on NASDAQ under the ticker symbol AVDL.
How many acquisitions has Avadel Pharmaceuticals made?
Avadel Pharmaceuticals has made 1 acquisition, including Eclat Pharmaceuticals.
Who are Avadel Pharmaceuticals's investors?
Avadel Pharmaceuticals has 6 investors. Key investors include Alkermes, RTW Investments, Vivo Capital, Avoro Capital Advisors, and Acuta Capital Partners.
What is Avadel Pharmaceuticals's ticker symbol?
The ticker symbol of Avadel Pharmaceuticals is AVDL on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.